Loxtra

Composition: 
Each ml of Loxtra contains: Ofloxacin 3.0 mg, Prednisolone Acetate 2.0 mg, Tetrahydrozoline Hydrochloride 0.4 mg, Benzalkonium Chloride 0.05 mg (as preservative), HPMC as a vehicle. 

Indications: 
Loxtra Sterile Ophthalmic Suspension is indicated for: 
For corticosteriod responsive inflammatory conditions of the conjunctiva, cornea and anterior segment of the eye where bacterial infection or a risk of bacterial infection exists. 

Presentation: 
Loxtra Sterile Ophthalmic Suspension, in 5 ml LDPE bottle.